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Abstract
Background: It has been known for over a decade that Plasmodium falciparum proteins are enriched in non-
globular domains of unknown function. The potential for these regions of protein sequence to undergo high levels
of genetic drift provides a fundamental challenge to attempts to identify the molecular basis of adaptive change in
malaria parasites.
Results: Evolutionary comparisons were undertaken using a set of forty P. falciparum metabolic enzyme genes,
both within the hominid malaria clade (P. reichenowi) and across the genus (P. chabaudi). All genes contained
coding elements highly conserved across the genus, but there were also a large number of regions of weakly or
non-aligning coding sequence. These displayed remarkable levels of non-synonymous fixed differences within the
hominid malaria clade indicating near complete release from purifying selection (dN/dS ratio at residues non-
aligning across genus: 0.64, dN/dS ratio at residues identical across genus: 0.03). Regions of low conservation also
possessed high levels of hydrophilicity, a marker of non-globularity. The propensity for such regions to act as
potent sources of non-synonymous genetic drift within extant P. falciparum isolates was confirmed at
chromosomal regions containing genes known to mediate drug resistance in field isolates, where 150 of 153
amino acid variants were located in poorly conserved regions. In contrast, all 22 amino acid variants associated
with drug resistance were restricted to highly conserved regions. Additional mutations associated with laboratory-
selected drug resistance, such as those in PfATPase4 selected by spiroindolone, were similarly restricted while
mutations in another calcium ATPase (PfSERCA, a gene proposed to mediate artemisinin resistance) that reach
significant frequencies in field isolates were located exclusively in poorly conserved regions consistent with genetic
drift.
Conclusion: Coding sequences of malaria parasites contain prospectively definable domains subject to neutral or
nearly neutral evolution on a scale that appears unrivalled in biology. This distinct evolutionary landscape has
potential to confound analytical methods developed for other genera. Against this tide of genetic drift,
polymorphisms mediating functional change stand out to such an extent that evolutionary context provides a
useful signal for identifying the molecular basis of drug resistance in malaria parasites, a finding that is of relevance
to both genome-wide and candidate gene studies in this genus.
Background
Identifying the molecular basis of disease-causing traits
is one of the major justifications for the recent expan-
s i o ni ng e n o m i cd a t ac o v e r i n gaw i d er a n g eo ft a x a .
Nowhere is this goal more clearly defined than in the
case of malaria, where adaptive evolution in the form of
drug resistance continues to undermine efforts to con-
trol human disease caused by P. falciparum [1] and P.
vivax [2]. Understanding the molecular basis of resis-
tance phenotypes is of great operational importance as
markers can be used to monitor spread and alternative
therapeutic strategies can be designed. Establishment of
a genetic cross has proven a fruitful starting point for
determination of the genotypic basis of drug resistance
[3-5], but is difficult, expensive and hence rarely
achieved in practice. Genomic epidemiological
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ward allowing detection of signatures of selection asso-
ciated with drug resistance [6], although this approach
relies on identification of linkage disequilibrium which
is known to be of variable strength [7]. Candidate gene
approaches based on other forms of data analysis may
also generate hypotheses suitable for further testing
[8,9].
Despite the power of these approaches for the discov-
ery of new drug-resistance genotypes, a decade has
passed since the description of the last confirmed resis-
tance gene for a widely used antimalarial [4]. It remains
exceptional for mutations hypothesized as being
involved in drug-resistance to be validated by transfec-
tion and phenotypic testing in P. falciparum, steps that
allow polymorphisms of true adaptive value to be discri-
minated from those that are present simply as a result
of genetic drift.
A specific phenomenon that may complicate studies in
this genus relates to the remarkable degree to which
Plasmodium proteins are enriched in non-globular
domains [10]. Since their first systematic description
more than a decade ago, the function of these domains
h a sr e m a i n e du n r e s o l v e d[ 1 1 - 1 3 ]w i t ho n ep o s s i b i l i t y
being that they represent downstream consequences of
events at the DNA level (i.e. broadly neutral in func-
tional terms). If this were to be the case, they would
represent potent generators of neutral or near neutral
non-synonymous polymorphism in line with central
concepts of modern evolutionary biology [14-16] that
will inevitably confound both genome-wide and candi-
date approaches to identifying the molecular basis of
resistance. Notably, minimal attempts have been made
to determine systematically the degree to which specific
areas of coding sequence have become released from
negative selective in the long-term, and by inference
unlikely to mediate functional change in the short-term.
Measurement of selective forces is still generally under-
taken at a whole-gene level, an approach that falls down
if pressures vary considerably within individual genes,
preventing determination of the true baseline for varia-
tion which is neutral evolution within and between
malaria species.
We reasoned that application of two basic biological
concepts could improve significantly the accuracy of
approaches designed to identify the genetic basis of
drug-resistance. Firstly, drug resistance, by necessity,
requires a significant functional change in the parasite,
and hence a functional change in one or more proteins.
Secondly, functionally important regions of proteins are
generally conserved across wide distances of evolution,
and can therefore be discriminated in orthologous
sequence alignments from sequences under minimal
constraint [17].
We undertook a systematic study of evolutionary pro-
cesses in Plasmodium coding sequences, revealing wide-
spread, dynamic variation in selection pressures within
individual coding sequences consistent with neutral the-
ories of evolution. The use of underlying conservation
score as an independent means of identifying functional
variation against the backdrop of genetic drift was vali-
dated and applied by examining the molecular basis of
drug-resistance, a phenotype that, by necessity, requires a
significant functional change in the parasite, and hence
frequently a functional change in one or more proteins.
Results
Polymorphism and divergence: whole-gene level
In order to study short-term evolutionary processes
within the hominid malaria clade a reference set of 40
P. falciparum genes (Table 1) was identified, consisting
of sequences well covered by genome sequencing of the
closely related primate parasite P. reichenowi [18]. Sin-
gle-nucleotide changes in these genes associated with
divergence (between P. falciparum 3D7 strain and P.
reichenowi) and intra-species polymorphism (within
sequenced P. falciparum isolates) were quantified. The
40-gene reference set contained 1270 fixed synonymous
differences between P. falciparum and P. reichenowi
indicating a synonymous pairwise divergence (dS) of
6.05%, a figure consistent with previous estimates [19].
There were 795 non-synonymous fixed differences (dN
= 0.92%) indicating an overall dN/dS ratio of 0.17, con-
sistent with broad negative selection across these genes.
This compares to a genome-wide assessment of fixed
differences between P. falciparum and P. reichenowi,
dN/dS = 0.21, and indicates that the sequences chosen
broadly capture the range of dN/dS ratios encountered
in the P. falciparum genome [18]. Within sequenced P.
falciparum isolates there were 83 synonymous and 102
non-synonymous polymorphisms (dN/dS ratio 0.31).
Non-synonymous changes hence constitute 55.1% of
intraspecies polymorphism but only 38.5% of interspe-
cies divergence, suggesting that approximately one-third
of observed amino acid variation within sequenced P.
falciparum isolates is deleterious and would naturally
undergo purifying selection over a longer period.
Conservation across the Plasmodium genus
Study of conservation across the Plasmodium genus was
undertaken using orthologous protein sequences from
the rodent parasite P. chabaudi,a sg e n o m es e q u e n c i n g
of P. chabaudi was at a more advanced stage at the
time of the studies than other available rodent species.
P. falciparum (3D7) protein sequences were compared
with P. chabaudi; an average score for all hominid
malaria variants would strictly be more accurate,
although this would only influence approximately 1% of
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Page 2 of 16residues. The mean level of protein conservation per
gene ranged widely across the reference set of 40 house-
keeping genes (mean +4.88 to -0.47 based on the BLO-
SUM62 matrix). It was also noted that overall 20.1% of
P. falciparum residues were non-aligned, compared to
13.3% for P. chabaudi, consistent with expansion of
non-aligned sequence in the hominid malaria lineage
since the last common ancestor of these species.
Correlation between short and long-term conservation
At the whole-gene level the dN/dS ratio for P. falci-
parum - P. reichenowi divergence strongly correlated
Table 1 Reference set of genes
P. falciparum gene Other identifier Product Pf amino acids P. chabaudi gene Pc amino acids
ATPases
PFA0300c MAL1P1.52 Vacuolar ATPase-coupled proton transport 383 PCHAS_020560 383
PFC0840w PfATPase7 Phospholipid transporting ATPase 1864 PCHAS_080610 1773
PFE0195w PfATPase3 Cation transporting ATPase 2393 PCHAS_110330 1904
PF07_0047 None Cell-division cycle ATPase 1229 PCHAS_122230 1106
PF08_0113 None Vacuolar proton transporting ATPase 1053 PCHAS_122440 957
PFI0240c None Cu
2+- transporting ATPase 2563 PCHAS_041740 2128
PFL0590c PfATPase4 Non-SERCA type Ca
2+-transporting ATPase 1208 PCHAS_020540 1468
PFL1125w MAL12P1.225 Phospholipid transporting ATPase 1618 PCHAS_144030 1601
Transporters
PFB0210c PfHT1 Hexose transporter 504 PCHAS_030470 505
PFB0465c PF02_0097 Monocarboxylate transporter 457 PCHAS_030940 456
PFE1185w MAL5P1.237 Metal transporter 684 PCHAS_123900 704
PFF0450c MAL6P1.94 Zn
2+ or Fe
2+ transporter 361 PCHAS_010830 338
PFF0170w MAL6P1.38 Calcium antiporter 441 PCHAS_010300 440
PFF1430c MAL6P1.133 Amino acid transporter 606 PCHAS_112780 617
PFI1295c None Monocarboxylate transporter 529 PCHAS_082700 507
PF11_0210 None Mg
2+,C o
2+ &N i
2+ channel 529 PCHAS_091640 435
PF11_0338 PfAQP Aquaglyceroporin 258 PCHAS_093040 258
MAL13P1.23 None CorA-like Mg
2+ transporter 468 PCHAS_140460 491
PF13_0252 PfNT1 Nucleoside transporter 422 PCHAS_136470 414
PF14_0679 None Inorganic anion antiporter 664 PCHAS_133900 700
Glycolytic
PFF1155w MAL6P1.189 Hexokinase 493 PCHAS_112240 494
PF14_0341 None Glucose-6-phosphate isomerase 579 PCHAS_100870 578
PFI0755c None 6-Phosphofructokinase 1418 PCHAS_081620 1306
PF14_0425 None Fructose-bisphosphate aldolase 369 PCHAS_131180 369
PF14_0378 None Triosephosphate isomerase 248 PCHAS_130700 248
PFI1105w PGK Phosphoglycerate kinase 416 PCHAS_082320 416
PF11_0208 None Phosphoglycerate mutase 250 PCHAS_091620 250
PF10_0155 None Enolase 446 PCHAS_121500 446
PFF1300w MAL6P1.160 Pyruvate kinase 511 PCHAS_112510 511
PF13_0141 PfLDH L-lactate dehydrogenase 316 PCHAS_134470 316
DNA/RNA
PFB0730w PF02_0151 DEAD/DEAH box helicase 1997 PCHAS_031480 1404
PFC0805w MAL3P6.20 DNA-directed RNA polymerase II 2457 PCHAS_080680 2307
PFE0465c MAL5P1.95 RNA polymerase I 2914 PCHAS_110870 2570
PFE0715w MAL5P1.144 Asparagine-tRNA ligase 1128 PCHAS_111360 1084
PFF1095w MAL6P1.201 Leucyl tRNA synthase 1447 PCHAS_112120 1251
MAL7P1.145 None Mismatch repair protein pms1 1330 PCHAS_020880 1094
PF13_0251 None DNA topoisomerase III 710 PCHAS_136460 676
PF14_0234 None DNA-directed DNA polymerase 1236 PCHAS_101890 989
PF14_0316 None DNA topoisomerase II 1472 PCHAS_101120 1460
PF14_0695 None DNA-directed RNA polymerase 861 PCHAS_134050 796
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1a, r
2 = 0.69, p < 0.0001); as expected dS showed no
such relationship. For polymorphism within P. falci-
parum (where interpretation of dN/dS is less straightfor-
ward [20]), non-significant trends of the same form were
seen (Figure 1b). Gene function also appeared to be
associated with the degree of purifying selection, with
glycolytic enzymes showing lower dN/dS values than the
other groups (Figure 1c) consistent with previous work
[18]. We compared our dN/dS scores for P. falciparum/
reichenowi divergence (Nei-Gojobori method with Jukes-
Cantor correction) with those previously reported for
the same 40 genes using maximum likelihood for calcu-
lation of dN/dS [18]. The two sets of results were well
correlated (Spearman r = 0.96) indicating that in relative
terms dN/dS is very similar for the differing methods; it
also confirms that the fixed difference datasets between
the two studies are highly comparable. The slope of the
line of correlation between our results and those of Jef-
fares et al. [18] was 0.81 suggesting that the Nei-
Gojobori analysis overestimates dN/dS to a small degree
compared to PAML.
A stratified analysis was undertaken in which each
amino acid residue was assigned to one of four levels of
cross-genus evolutionary conservation according to P.
falciparum - P. chabaudi CLUSTALW alignment. Resi-
dues were defined as non-aligned, non-conserved (-4 to
-1), semi-conserved (0 to +3) and identical (+4 and
above) on the basis of the BLOSUM62 matrix. Synon-
ymous substitution rates within the hominid malaria
clade were similar across all levels of conservation (Fig-
ure 2a) but non-synonymous substitution rates were
strongly influenced by long-term evolutionary context
(Figure 2b). The dN/dS ratio for divergence was
approximately 20-fold higher at non-aligning residues
(0.64) compared to residues identical across the genus
(0.034; Table 2). Chi-squared testing comparing diver-
gence with polymorphism (McDonald-Kreitman test)
within each conservation stratum showed that strong
purifying selection was largely confined to residues
Figure 1 Hominid malaria clade divergence and conservation across the Plasmodium genus. For the forty individual genes of the
reference set, dN/dS and dS are plotted against mean conservation score for each gene. (a) Fixed differences between P. falciparum and P.
reichenowi. (b) Polymorphisms within P. falciparum. (c) dN/dS ratios for fixed differences between P. falciparum and P. reichenowi according to
functional group.
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dence for purifying selection in non-aligned sequence
regions.
Relationship between evolutionary conservation,
hydrophilicity and informational complexity
Given the lack of a gold-standard informatic approach
to defining non-globular regions, the relationship
between conservation and non-globularity was explored
via one purely structural marker of non-globularity
(Kyte-Doolittle hydrophilicit y )a sw e l la sap u r e l yi n f o r -
mational one (low-complexity regions defined by the
SEG algorithm). These studies were undertaken in the
context of an approach to cross-genus conservation
measurement designed for high throughput use, invol-
ving a sliding window of 9 amino acid residues.
Decreasing cross-genus conservation was linked to
both a shift to unusually high hydrophilicity scores, with
a clear inflexion point present between conservation
scores of 2 and 3 (Figure 3), and a reduction in strength
of negative selection within the hominid malaria clade
(Figure 4). A minority (31%) of sequence with conserva-
tion score less than 2.5 was responsible for 77% of non-
synonymous differences between P. falciparum and P.
reichenowi, including 87% of radical substitutions (Fig-
u r e4 c ) .L o w - c o m p l e x i t yr e g i o n sd e f i n e db yt h eS E G
Figure 2 Mutation rates within the hominid malaria clade stratified by conservation level across the Plasmodium genus. (a)
Synonymous substitution rates. (b) dN/dS ratios. Data are based on 40 reference genes. Fixed differences between P. falciparum and P.
reichenowi are indicated by filled grey bars; polymorphism within P. falciparum is indicated by empty bars. Error bars represent 95% confidence
intervals. Conservation levels were based on BLOSUM62 score at individual amino acids in P. falciparum - P. chabaudi alignments; identical (+4
and above), semi-conserved (0 to +3), non-conserved (-4 to -1) and non-aligned.
Table 2 Divergence and polymorphism in reference genes assessed by McDonald-Kreitman test, stratified by level of
cross-genus conservation
Conservation level dN/dS Adjusted dN/dS Synonymous Non-synonymous Chi-squared Neutrality Index
Identical 0.030 0.034 D 839 101 8.3 × 10
-15 5.6
P5 2 3 5
Semi-conserved 0.21 0.24 D 186 174 0.22 1.6
P1 2 1 8
Non-conserved 0.35 0.39 D 90 118 0.38 1.5
P7 1 4
Non-aligned 0.55 0.64 D 155 402 0.74 1.1
P1 2 3 5
Total 0.15 0.17 D 1270 795 9.5 × 10
-6 2.0
P 83 102
dN/dS ratios refer to P. falciparum /P. reichenowi divergence. Conservation levels were based on BLOSUM62 score in P. falciparum - P. chabaudi alignments;
identical (+4 and above), semi-conserved (0 to +3), non-conserved (-4 to -1) and non-aligned. Adjusted dN/dS ratios were derived based on the transition:
transversion ratio measured at 4-fold degenerate sites (see Table 4). D = divergent mutations, P = polymorphisms. Chi-squared and Neutrality Index are the
outputs of the McDonald-Kreitman test; neutrality index indicates the extent to which the levels of variation depart from the expected in the neutral model with
values greater than 1 indicating an excess of polymorphism and hence negative selection.
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sequence studied (missing many poorly conserved
regions of sequence and including some highly con-
served areas), and contained only 19.0% of non-synon-
ymous differences between P. falciparum and P.
reichenowi. Taken together these observations indicate
that a measurement of cross-genus evolutionary conser-
vation identifies highly hydrophilic sequences that show
relaxed purifying selection in the short-term, features of
non-globular domains, and that this method appears
superior to an approach based purely on informational
complexity.
Chromosomal regions containing genes responsible for
drug resistance in field isolates
In order to test the utility of this approach for detect-
ing functional variation in P. falciparum,w ee x a m i n e d
three chromosomal regions containing PfCRT,
PfDHFR and PfDHPS, testing polymorphisms between
two pairs of sensitive and resistant parasite isolates in
each case. As observed with the reference genes, there
were wide ranging levels of long-term conservation
(Figure 5), and a similar shift to very high levels of
hydrophilicity at conservation scores below 3 in all
three cases (Figure 6). Indeed, the proportion of
sequence falling below a conservation threshold of 2.5
was even greater than in the reference gene set (56%
vs. 31%) indicating that at a genomic level non-globu-
l a rd o m a i n sm a yb er e s p o n s ible for an even higher
proportion of non-synonymous polymorphism than in
our reference genes. Consistent with this, amino acid
variants in genes not involved in drug resistance fell
almost exclusively in less conserved regions with 150
of 153 such amino acid variants below the 2.5 conser-
vation threshold (Figure 5g, Chi-squared test for pro-
portion of mutations vs. proportion of total sequence
at each conservation level: p = 9 × 10
-23). In contrast
22 amino acid variants within known drug-resistance
genes were located in more conserved regions (Chi-
squared test for proportion of mutations vs. propor-
tion of total sequence at each conservation level: p =
3.8 × 10
-7), with all mutations being located at
Figure 3 Density plot of conservation vs. hydrophilicity for amino acid residues of 40 reference genes. (a) Number of occurrences at
each co-ordinate (using bins of 0.1 on both × and Y-axes). (b) Average hydrophilicity (conservation score bins of 0.2). Conservation levels in P.
falciparum - P. chabaudi alignments were based on BLOSUM62 score using a sliding, overlapping window of 9 residues; hydrophilicity was based
on the Kyte-Doolittle index (sliding, overlapping window of 14).
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3.0). Further there was no overlap in conservation
scores between amino acid variants in the drug-resis-
tance gene and those within other genes within any
single alignment. These results indicate that the posi-
tion of mutations within a long-term and measurable
evolutionary landscape provides a robust signature
that can aid identification of functionally important
amino acid variants.
Laboratory-selected drug resistance
Fourteen amino acid variants associated with selection
of atovaquone, azithromycin and spiroindolone resis-
tance in vitro (involving mitochondrial, apicoplast and
nuclear genomes respectively [21-23]) conformed to the
same pattern (Figure 7). Combining these with field
resistance mutations produced a set of 36 non-
synonymous polymorphisms associated with drug resis-
tance. Notably, among these mutations the nature of the
amino acid variants itself (radical vs. conservative) pro-
vided no discriminatory value, indicating that it is pri-
marily the location of the protein change that
distinguishes functional adaptation.
Population data from P. falciparum isolates
Evolutionary analysis of long-term conservation is also
relevant to population studies on large numbers of field
samples since the neutral theory of evolution describes a
strong relationship between selective pressure and allele
frequency [24]. Sequences of PfSERCA, a postulated tar-
get of artemisinin, have been determined for thousands
of isolates across the world (See Table 3 for data
sources). Consistent with neutral evolution, maximum
allele frequencies for amino acid variants in PfSERCA
Figure 4 Conservation-hydrophilicity at sites of amino acid variants in 40 reference genes. (a) Conservative amino acid variants between
P. falciparum and P. reichenowi. (b) Radical amino acid variants between P. falciparum and P. reichenowi. (c) Proportion of total sequence,
conservative amino acid variants and radical amino acid variants according to conservation level (conservation score bins of 1.0). Conservation
and hydrophilicity were derived as for Figure 3.
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regions. For each of three drug-resistance regions, two comparisons between resistant and sensitive isolates were made. (a, b) CRT resistance
locus on chromosome 7. (c, d) DHFR resistance locus on chromosome 4. (e, f) DHPS locus on chromosome 8. Mutations in known drug-
resistance genes are shown as filled circles; other mutations are shown as open circles. A threshold conservation score of 2.5 is indicated by the
dotted line. Only coding regions are displayed, with gene designations and colours used for orientation purposes only. (g) Proportion of total
sequence, amino acid variation in drug-resistance genes and amino acid variation in other genes according to conservation level (based on a
sliding window of 9 residues, with conservation scores shown within bins of 1.0).
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Page 8 of 16were linked closely to cross-genus conservation level. All
mutations reaching a prevalence of more than 25% were
located in regions of low conservation (Figure 8a),
matching the pattern of fixed differences between P. fal-
ciparum and P. reichenowi SERCAs. The opposite
pattern was seen with amino acid variants associated
with spiroindolone resistance in PfATPase4, which stand
out distinctly against the flow of corresponding amino
acid variants between P. falciparum and P. reichenowi
ATPase4 sequences (Figure 8b).
Figure 6 Density plot of conservation vs. hydrophilicity for 3 drug resistance regions. Left: Number of occurrences at each co-ordinate
(using bins of 0.1 on both × and Y-axes). Right: Mean hydrophilicity by conservation score (bins of 0.2). Conservation and hydrophilicity are
derived as for Figure 3.
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Non-adaptive evolution in Plasmodium
We show that genes that maintain synteny and clearly
defined orthologous relationships across the genus also
contain poorly conserved domains that occupy approxi-
mately half of the total coding sequence when analysed
at the chromosomal level. In other words, in Plasmo-
dium species, negative (purifying) selective force is unu-
sually chimeric in nature, being alternately strong and
weak within the same gene. Plasmodium chabaudi has
approximately two-thirds as much non-aligned sequence
as P. falciparum, while other work on a genome-wide
scale indicates that P. vivax has approximately 40% [25].
This indicates that the phenomenon is genus-wide,
being particularly marked in the hominid malaria clade.
The reason why internal proteins mediating core biolo-
gical functions possess such widespread areas of non-
globular domain experiencing minimal purifying selec-
tion remains obscure but our data are certainly consis-
tent with these sequences representing a downstream
consequence of genetic processes [13,26] such as repli-
cation slippage and unequal crossing over [27]. The dN/
dS ratio of 0.64 in non-aligned regions suggests that
these sequences are under very weak negative selective
Figure 7 Conservation-hydrophilicity plot for amino acid
variants associated with drug resistance or within drug-
resistance regions. All mutations shown to be involved in drug
resistance by transfection (22 nSNPs in CRT, DHFR and DHPS) or
drug pressure studies (14nSNPs in cytochrome b, rpl4 and
PfATPase4) are shown along with variants in chromosomal regions
around CRT, DHFR and DHPS (see Figure 5).
Table 3 Maximum field allele frequencies for non-
synonymous mutations in PfSERCA (PFA0310c, PfATP6)
Mutation Frequency (%) Location Reference
R37K 100 Venezuela [54]
K67R 3 Ghana [54]
K88E 1 Tanzania [54]
I89T 38 Philippines [54]
S176N 3 Malawi [54]
V229I < 1 Zanzibar [55]
I230T 3 Iran [54]
H243Y 5 Malawi [54]
A338V 1 Tanzania [54]
L402V 28 Brazil [56]
D405N 1 Tanzania [54]
E431K 58 Ethiopia [57]
E432K 36 Cameroon [58]
D436N 3 Tanzania [54]
A438D 18 Vanuatu [54]
N462D 10 Venezuela [54]
N463S 3 Vietnam [59]
464 del 2 Cambodia [60]
N465S 16 Thailand [1]
S466N 35 Peru [61]
S529I 3 Tanzania [54]
K561N 1 Niger [62]
N569K 36 Zanzibar [55]
G585D < 1 Zanzibar [55]
T602I < 1 Zanzibar [55]
L610I 1 Tanzania [54]
K611N < 1 Zanzibar [55]
N612D < 1 Zanzibar [55]
A621D < 1 Zanzibar [55]
A623E 4 Ethiopia [57]
A630S 58 Brazil [56]
G632E 3 Malawi [54]
T635K 16 Madagascar [54]
E637G < 1 Zanzibar [55]
G639D 90 Venezuela [54]
S641G < 1 Zanzibar [55]
E643Q 1 Zanzibar [55]
N644I 1 Zanzibar [55]
K649E < 1 Zanzibar [55]
L650W 2 Bangladesh [54]
T657I 3 Malawi [54]
N683K 9 Bangladesh [54]
I723V 3 Tanzania [54]
H747Y 11 Madagascar [54]
S769N 4 Ethiopia [57]
K771A 4 Angola [63]
K776N 1 Angola [63]
K783E 1 Tanzania [54]
G805E 3 Malawi [54]
R809G < 1 Zanzibar [55]
844 del 77 Peru [61]
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maintain non-globular structure.
Applications
Improved understanding of these issues has major impli-
cations for the study of all Plasmodium biology that
relates to evolution. The findings are most immediately
relevant to the goal of understanding molecular
mechanisms of drug resistance, since this represents a
classical example of evolution in action. As predicted,
we were able to show that mutations selected by drug
pressure in the field or laboratory are located in con-
served protein sequences that have remained largely
unchanged for millions of years (being conserved across
the Plasmodium genus) by virtue of their functional
importance, as already noted by other authors
[22,28-30]. What has not been considered is that the
gradient in purifying selective force across the genus is
strong enough to allow drug-resistance mutations to be
discriminated accurately from those that are likely to
non-adaptive in nature. Prediction of the functional con-
sequences of mutations based on long-term evolutionary
conservation has been described in the context of
human genetic studies [31-33] but there is even greater
scope for this approach to assist studies in P. falci-
parum, where the contribution of non-adaptive change
appears to be log-orders of magnitude higher.
The potential for non-adaptive evolution to confound
studies of genotype-phenotype relationships is clear in
several areas. Candidate gene surveys based on sequen-
cing of field isolates, where few or no phenotypic data
are available, provide an obvious example; the majority
of polymorphisms found in PfSERCA are seen to be
located in poorly conserved regions, including all those
reaching frequencies of more than 25% in field isolates.
This finding indicates that polymorphism in this gene is
dominated by non-adaptive evolution, and the tempta-
tion to invoke positive selection [34] should be avoided.
Use of dN/dS to infer positive selection in whole gen-
ome analyses of P. vivax [35] may also be prone to the
same issue; although measures of dN/dS across a gene
tend to be conservative due to purifying selection, it is
still likely on statistical grounds that across a large num-
ber of genes, a number of high dN/dS ratios (greater
than one) will be generated simply by the action of non-
adaptive evolution.
Understanding of the degree to which non-adaptive
evolution occurs is also relevant to the identification of
Table 3 Maximum field allele frequencies for non-synon-
ymous mutations in PfSERCA (PFA0310c, PfATP6)
(Continued)
D845N 3 Tanzania [54]
E847K 2 Thailand [1]
T857S 1 Tanzania [54]
A1115G 4 Papua New Guinea [54]
V1169I 24 Brazil [54]
S1187T 3 Ghana [54]
D1228E 3 Ghana [54]
3D7 sequence was used as reference. Only studies where alleles were
determined for at least ten samples were included. Samples with mixed
infections were included in each numerator.
Figure 8 Conservation-hydrophilicity plots and single-
nucleotide changes in the hominid malaria clade in calcium-
ATPase genes. (a) PfSERCA (PFA0310c) showing amino acid
variants between P. falciparum and P. reichenowi and field amino
acid variants (see Table 3); symbol size indicates maximum allele
frequency on a countrywide basis. (b) PfATPase4 (PFL0590c),
showing amino acid variants between P. falciparum and P.
reichenowi as well as the mutations associated with spiroindolone
selection (see text). Conservation and hydrophilicity are derived as
for Figure 3.
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Page 11 of 16drug-resistance genes in a chromosomal context. In our
analyses of regions known to contain drug-resistance
genes, application of evolutionary conservation added
considerable specificity with more than 95% of muta-
tions outside drug-resistance genes falling into poorly
conserved sequence. Nevertheless the accuracy of the
evolutionary approach as it stands is unlikely to be suffi-
cient for its use in isolation, but rather as a method for
pinpointing polymorphisms within regions identified by
other means, particularly genome-wide association stu-
dies using population genetic tests [6,36]. Genetic cross
experiments are also a robust starting point; for exam-
ple, the complex polymorphisms in the cg1 and cg2
genes seen at the chloroquine resistance locus identified
by the cross of HB3 and DD2 [37] would be defined as
being of low priority for further study by the approach
we describe. Further work is in progress to examine sys-
tematically the evolutionary properties of other regions
already identified as being of phenotypic importance by
experimental means [38], with the aim of prioritizing
polymorphisms for more detailed studies.
Wider relevance
Awareness of the chimeric selection landscape of Plas-
modium coding sequences is also relevant to the study
of the history of Plasmodium species. A higher dN/dS at
the whole gene level for hominid parasites P. falciparum
and P. reichenowi compared to rodent malaria parasites
has been suggested to provide evidence for small popu-
lation size during the P. falciparum-reichenowi diver-
gence [39]. However, based on the set of forty reference
genes we studied, hominid malaria proteins contain sig-
nificantly more non-aligned sequence than do rodents,
likely leading to higher dN/dS ratios at the whole gene
level. In fact in sequence regions conserved across the
Plasmodium genus the average dN/dS ratio for the P.
falciparum-P. reichenowi divergence was 0.034, indicat-
ing strong purifying selection and implying a historically
large population size following the lateral transfer of P.
falciparum to humans from bonobos [40] or gorillas
[41].
Conclusion
The coding sequences of Plasmodium species exemplify
the theories of neutral evolution [14,42] and the ensuing
nearly neutral theory [15], operating on a grand scale
that to our knowledge is unrivalled in genome biology.
Failing to take into account the effect of this in any
work that relates to evolution of coding sequence repre-
sents a missed opportunity to distinguish adaptive from
non-adaptive polymorphism. For example neither gen-
ome-wide or candidate gene association studies into
antimalarial resistance currently take into account the
fact that most polymorphism is non-adaptive in nature.
T h ea p p r o a c hw ed e s c r i b et a k e sa d v a n t a g eo fp r o t e i n
sequence data, but does not require any knowledge of
protein function, a major advantage since the elucida-
tion of function for the majority of Plasmodium genes
remains a distant goal. Application of this method on a
genome-wide scale, where it can be integrated into
DNA-based methods as well as candidate gene
approaches, offers a powerful approach for future stu-
dies in the field of antimalarial resistance, as well as
other areas of research that are linked to evolutionary
biology in this important genus.
Methods
Comparisons between P. falciparum and P. chabaudi
orthologs
The rodent malaria species Plasmodium chabaudi was
used as comparator species given its status in terms of
genome completion. Protein and DNA sequences (Plas-
modb version: 2009.03.24) were obtained from Plas-
modb.org. Forty orthologous pairs of sequences were
chosen, fulfilling the following criteria; no known or
hypothesised role in drug resistance or host interaction,
syntenic relationship between P. falciparum and P. cha-
baudi and > 75% coverage in the P. reichenowi ortholog
[18] (used for measurement of divergence within homi-
nid malaria parasites). Since sexual-stage genes are
released from purifying selection in asexual culture
(experienced by several of the isolates under study) [43]
genes with no evidence of asexual expression in tran-
scriptomic surveys [44,45] were also excluded. In order
to reflect the types of genes which are implicated in
drug resistance, as well as to obtain a range of conserva-
tion levels across this reference set, the reference genes
consisted of ATPases (8), secondarily active transporters
(12), glycolytic enzymes (10) and enzymes involved in
DNA and RNA processing (10)(Table 1). The Plasmodb
gene model for PfL0590c (PfATPase4) was found to be
inconsistent with published data based on cDNA; the
latter were used as coding sequence [23].
CLUSTALW alignments of orthologous protein
sequences from P. falciparum and P. chabaudi were per-
formed using the default settings of BioEdit. BLOSUM62
scores (reflecting conservation) were then calculated for
each P. falciparum residue. Regions that could not be
aligned between P. falciparum and P. chabaudi orthologs
were defined as the gaps in BLASTP alignments of P. fal-
ciparum and P. chabaudi orthologs (BLOSUM62 matrix,
gap penalties: existence 9, extension 2) A manual check
of the protein alignment in BioEdit was also performed
and on rare occasions where short alignments had been
excluded by the BLASTP search these were retained. For
residues where there was no aligned P. chabaudi residue,
a conservation score of -5 was applied. Relatively small
regions with no P. reichenowi coverage were also
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tors for inter- and intra-species comparison.
Annotation of polymorphisms and fixed differences
We analysed single-nucleotide polymorphisms (SNPs)
derived from Plasmodb, based on available sequence for
various P. falciparum strains from around the world
generated by the Broad Institute [46], Wellcome Trust
Sanger Institute [18] and NIH [47]. Fixed differences
between P. falciparum 3D7 strain and P. reichenowi
(Oscar strain) were also obtained from Plasmodb [18].
Radical amino acid substitutions were defined as those
with BLOSUM62 matrix score < 0.
The challenge of identifying single nucleotide changes
within a sequence that is undergoing frequent insertion-
deletion polymorphism has been described [48]. In addi-
tion, we noted that although complex polymorphisms
were said to be excluded in publications, the Plasmodb
lists of SNPs within P. falciparum and fixed differences
between P. falciparum 3D7 strain and P. reichenowi
sometimes contained repetitive mutations within tandem
repeats (confirmed by Pustell protein matrix, MacVector)
that were clearly part of complex indel polymorphisms
and hence not genuine SNPs. These regions contributed
27.5% of all SNPs among P. falciparum isolates and 9.4%
of the interspecies divergence, and were excluded from
both polymorphism and divergence analyses.
Calculation of positions and transitions
Calculation of synonymous and non-synonymous posi-
tions was undertaken for each P. falciparum ortholog
using a standard substitution matrix (assuming equal
mutation rates) with Jukes-Cantor correction [49]. Con-
fidence intervals for dS were determined assuming a
continuous distribution. Confidence intervals for dN/dS
were determined using the delta method. Transitional
bias was determined by studying synonymous fixed dif-
ferences between P. falciparum and P. reichenowi ortho-
logs occurring at amino acids encoded by four codons.
Consistent with previous measurements on a chromoso-
mal scale [50], synonymous sites made up 20.1% of all
sites within the reference genes (See Table 4) with 8.9%
of sites being 4-fold degenerate sites (nucleotide
positions at which all mutations are synonymous). For
synonymous differences at 4-fold degenerate sites, which
we assume are selectively neutral, transitions made up
41.4% of changes and transversions 58.6%, consistent
with a moderate transitional bias that would produce
falsely low dN/dS ratios [51] (since transitional muta-
tions are associated with degeneracy at many 2-fold
degenerate sites). Taking this factor into account led to
upwards revision of dN/dS ratios for divergence of
between 12 and 16% according to the level of conserva-
tion; the effect was greatest for non-aligned sequence
where the adjusted dN/dS ratio rose to 0.64 (Table 1).
Studies of hydrophilicity and complexity
Hydrophilicity scores were measured by the Kyte-Doo-
little index (window = 14). Low-complexity regions were
defined using the SEG algorithm at its default para-
meters [52].
Drug-resistance chromosomal regions
P. chabaudi orthologs were again used to generate the
conservation score. In the case of one gene (MAL8P1.111)
there was no rodent malaria parasite ortholog as pre-
viously reported [53] and in consequence the syntenic P.
vivax ortholog was used for comparison. For the single
apicoplast gene rpl4 the partial P. chabaudi sequence
PC103611.00.0 was available for generation of the cross-
genus conservation score at sites of mutation. For all stu-
dies at drug-resistance regions a neighbourhood conserva-
tion score was used (averaging the individual conservation
scores across a sliding, overlapping window of 9 residues).
This allows for the possibility that drug-resistance muta-
tions may occur at residues that have previously under-
gone conservative change within a wider area of
conservation, thereby reducing stochastic loss of sensitiv-
ity. This also obviated the need for a specific step to iden-
tify non-aligned regions at genomic regions. Non-
synonymous SNPs (nSNPs) between sensitive and resistant
parasites were studied at each locus, spanning the drug-
resistance gene in each case and extending outwards sym-
metrically until 10 nSNPs outside the drug-resistance gene
itself had been documented in at least one pairwise com-
parison. All residues known to be intrinsic to resistance
Table 4 Synonymous sites in reference set of genes
Conservation level All 4-fold Transitional sites Transversional sites Adjusted S
Identical 14127 (20.8) 6384 (9.4) 6389 (9.4) 1354 (2.0) 15537
Semi-conserved 2889 (19.1) 1249 (8.3) 1319 (8.7) 321 (2.1) 3176
Non-conserved 1609 (21.5) 811 (10.9) 672 (9.0) 126 (1.7) 1759
Non-aligned 3240 (17.7) 1187 (6.5) 1819 (10.0) 234 (1.3) 3658
Total 21866 (20.1) 9631 (8.9) 10200 (9.4) 2036 (1.9) 24131
Transitional sites refer to 2-fold synonymous codons by virtue of transitional substitution; transversional sites to 2-fold synonymous codons by virtue of
transversional substitution. Numbers in parentheses indicate proportion (%) of total positions.
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Page 13 of 16haplotypes, whether or not each individual residue has
been shown to cause drug-resistance independently, were
included. Chi-squared testing was undertaken testing
whether the distribution of amino acid variants in terms of
conservation level was the same as the distribution of total
sequence, using 13 conservation levels (bins of 1), and
hence 12 degrees of freedom. The test was performed first
for drug-resistance genes and mutations, and then for the
other genes and the mutations within them.
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